Identification of an Orally Efficacious GPR40/FFAR1 Receptor Agonist

被引:7
作者
Agarwal, Sameer [1 ]
Sasane, Santosh [1 ]
Deshmukh, Prashant [1 ]
Rami, Bhadresh [1 ]
Bandyopadhyay, Debdutta [1 ]
Giri, Poonam [1 ]
Giri, Suresh [1 ]
Jain, Mukul [1 ]
Desai, Ranjit C. [1 ]
机构
[1] Cadila Healthcare Ltd, Zydus Res Ctr, Sarkhej Bavla NH 8 A, Ahmadabad 382210, Gujarat, India
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2016年 / 7卷 / 12期
关键词
GPR40; agonist; FFAR1; fatty acids; insulin secretion; type; 2; diabetes; BIOAVAILABLE GPR40 AGONIST; TYPE-2; DIABETES-MELLITUS; INSULIN-SECRETION; DOUBLE-BLIND; DISCOVERY; POTENT; TAK-875; TARGETS; SAFETY;
D O I
10.1021/acsmedchemlett.6b00331
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
GPR40/FFARI is a G protein-coupled receptor predominantly expressed in pancreatic beta-cells and activated by long-chain free fatty acids, mediating enhancement of glucose stimulated insulin secretion. A novel series of substituted 3-(4-aryloxyaryl)propanoic acid derivatives were prepared and evaluated for their activities as GPR40 agonists, leading to the identification of compound 5, which is highly potent in in vitro assays and exhibits robust glucose lowering effects during an oral glucose tolerance test in nSTZ Wistar rat model of diabetes (ED50 = 0.8 mg/kg; ED90 = 3.1 mg/kg) with excellent pharmacokinetic profile, and devoid of cytochromes P450 isoform inhibitory activity.
引用
收藏
页码:1134 / 1138
页数:5
相关论文
共 25 条
[1]   Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination procedures [J].
AbdelMagid, AF ;
Carson, KG ;
Harris, BD ;
Maryanoff, CA ;
Shah, RD .
JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (11) :3849-3862
[2]   Discovery of a Potent and Orally Efficacious TGR5 Receptor Agonist [J].
Agarwal, Sameer ;
Patil, Amit ;
Aware, Umesh ;
Deshmukh, Prashant ;
Darji, Brijesh ;
Sasane, Santosh ;
Sairam, Kalapatapu V. V. M. ;
Priyadarsiny, Priyanka ;
Giri, Poonam ;
Patel, Harilal ;
Giri, Suresh ;
Jain, Mukul ;
Desai, Ranjit C. .
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (01) :51-55
[3]   Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes [J].
Ahren, Bo .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (05) :369-385
[4]  
[Anonymous], 2013, IBD DIAB ATL
[5]   Non-insulin therapies for type 2 diabetes [J].
Ashiya, Mona ;
Smith, Richard E. T. .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (10) :777-778
[6]   Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes [J].
Christiansen, Elisabeth ;
Hansen, Steffen V. F. ;
Urban, Christian ;
Hudson, Brian D. ;
Wargent, Edward T. ;
Grundmann, Manuel ;
Jenkins, Laura ;
Zaibi, Mohamed ;
Stocker, Claire J. ;
Ullrich, Susanne ;
Kostenis, Evi ;
Kassack, Matthias U. ;
Milligan, Graeme ;
Cawthorne, Michael A. ;
Ulven, Trond .
ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (05) :441-445
[7]   Recent developments in the discovery of FFA1 receptor agonists as novel oral treatment for type 2 diabetes mellitus [J].
Defossa, Elisabeth ;
Wagner, Michael .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (14) :2991-3000
[8]   From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus [J].
DeFronzo, Ralph A. .
DIABETES, 2009, 58 (04) :773-795
[9]   Synthesis and activity of small molecule GPR40 agonists [J].
Garrido, DM ;
Corbett, DF ;
Dwornik, KA ;
Goetz, AS ;
Littleton, TR ;
McKeown, SC ;
Mills, WY ;
Smalley, TL ;
Briscoe, CP ;
Peat, AJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (07) :1840-1845
[10]   Discovery of a Potent Free Fatty Acid 1 Receptor Agonist with Low Lipophilicity, Low Polar Surface Area, and Robust in Vivo Efficacy [J].
Hansen, Steffen V. F. ;
Christiansen, Elisabeth ;
Urban, Christian ;
Hudson, Brian D. ;
Stocker, Claire J. ;
Due-Hansen, Maria E. ;
Wargent, Ed T. ;
Shimpukade, Bharat ;
Almeida, Reinaldo ;
Ejsing, Christer S. ;
Cawthorne, Michael A. ;
Kassack, Matthias U. ;
Milligan, Graeme ;
Ulven, Trond .
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (06) :2841-2846